New Blood Glucose Meter Guidance Unveiled: A Discussion with the FDA


Price: $0.00

Join us for this 60-minute webinar and ask FDA's Director of the Division of Chemistry and Toxicology Devices your questions about how the new draft guidance documents for glucose meters will affect the regulation and use of these instruments. If these documents are implemented as currently written, glucose meters used in professional settings could become moderate complexity tests, requiring labs and POCT programs that use these instruments to comply with CLIA's moderate complexity requirements. Register for this webinar and learn how blood glucose meters are currently regulated, understand the new professional use requirements, and get the answers you need about how this initiative may affect point-of-care glucose testing at your institution.